Navigation Links
David M. Boitano Promoted to Senior Vice President
Date:5/16/2008

NEWPORT BEACH, Calif., May 16 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) announced today the promotion of David M. Boitano to Senior Vice President and Senior Investment Officer. "Dave has made a tremendous contribution to NHP over the last several years as evidenced by our strong investment growth and diversification strategy successes. Dave has been responsible for over $1 billion in accretive investments for NHP, leveraging his vast experience and relationships in healthcare real estate and operations," said Don Bradley, NHP's Chief Investment Officer.

Since 2002, Mr. Boitano has been an investment officer for NHP focused primarily on senior housing and long-term care acquisition and development opportunities in the West. Mr. Boitano also led the deal team responsible for our initial portfolio of seven medical office buildings in Southwest Washington acquired in association with Pacific Medical Buildings and will work closely with them on future MOB acquisition and development projects.

Prior to joining NHP, Mr. Boitano was the Senior Vice President of Finance and Acquisitions and Treasurer for a leading senior housing provider. During his 13-year career in senior housing, Mr. Boitano has been involved in financing over $3.0 billion of healthcare real estate as a REIT investor or operator.

Nationwide Health Properties, Inc. is a real estate investment trust that invests in senior housing facilities, long-term care facilities and medical office buildings. The Company has investments in 555 facilities in 43 states. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

CONTACT: Do
'/>"/>

SOURCE Nationwide Health Properties, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lt. Gov. David Dewhurst announces $5M TETF investment in UTHSC-H trauma research
2. St. Davids HealthCare Granted the States Top Honor for Quality and Performance Excellence
3. NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
4. St. Davids HealthCare and Texas Cardiac Arrhythmia Announce International Center For Training, Research and Treatment of Heart Rhythm Disorders
5. David Pizzo Appointed Blue Cross and Blue Shield of Florida Market President - West Florida
6. NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors
7. NCRA Urges Congressman David Wu to Approve in Conference the Higher Education Reauthorization Bill Providing Closed Captioning for 30 Million Deaf and Hard-of-Hearing Americans
8. CIFG Names David Rockwell Chief Risk Officer; Thierry Dissaux to Head European Operations
9. Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors
10. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
11. Senior Obama Strategist David Axelrod and Wife Susan to be Honored for Their Decade-Long Commitment to Epilepsy Research at NYC Benefit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBa...tion,slargestmedicalcliniconDec.9-10,whenKansasCit...nsuredpeople. ,, "Thisfreecliniceventhasthepote...wodaysinsteadofjustoneandbeheldonweekdaysinsteadof...asCityFreeHealthClinicandpresidentoftheNationalAss...
(Date:11/25/2009)... ,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNew...eFDA,sCenterforDrugEvaluationandResearch,titled"AD...A,"appearsintheNov.26,2009issueofTheNewEnglandJour.../cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticl...enaccesstopainmedicationforthosewhoneeditandmanagi...
(Date:11/25/2009)... , Researchers have found evidence of a statistic...moxifen among patients whose estrogen receptor (ER...on of ER-alpha; at serine-118 (ER-alpha S118-P), a... November 25 in the Journal of the National Cance...inomas are resistant to tamoxifen. Preclinical stu...
(Date:11/25/2009)... , Evaluation and treatme... Woodstock (Vocus) November 25, 2009 ...1N1 nasal vaccines and H1N1 vaccine shots at four ...nce another shipment of vaccine has arrived. The c...stal Lake and McHenry and will be open as follows:...
(Date:11/25/2009)... ,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswi...ew"PreventHealthCareFraudActof2009,"S.2128,whichis...ilabletopreventfraudinMedicare.Thebillwasintroduce...containsseveralprovisionstheAmericanAssociationfor...whichtheAssociationproposedtoCongressinFebruary.Th...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...fically press photographers have been suspected of...picion was unveiled// by a health official belongi...of our working hypotheses. Bird flu can be transmi... across the country,' said the health official. ...
...study conducted by India and Canada which was carr... research institute reported// a decrease in the H...15 to 24 years suffering from HIV in the states of...h Indian states. The four states account for ...
...for the elders to slip into the past and reminisce...th, but psychologists warn// that such frequent re...with the present. This phenomenon becomes a p...peating boring old yarns, it is not a normal sympt...
...ria and Tuberculosis in most developing countries ...opean Union, UNAIDS, WHO and the Indian Government...strategy against the diseases. "These diseas...he diseases in various countries," Mr.Alexander Sp...
...VT) or clot formation is on the rise among patient...r Liam Smeeth, from the London School of Hygiene a...ook at whether infection could trigger DVT or pulm...he London team found those who had suffered either...
...S. health regulators, gave their nod to the first ...tion in heart transplant patients.// The drug, ... to prevent rejection of liver and kidney transpla...ants in the U.S. each year will now have a new opt...
Other Medicine News:Health News:Reminiscing Into The Past Makes You Dissatisfied With The Present 2Health News:DVT Risk Increased After Acute Infections 2
(Date:11/25/2009)...TheFDAgrantedtraditionalapprovalforINTELENCE®...ptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspeci...swhoareexperiencingvirologicfailurewithHIV-1strain...ts.Thetraditionalapprovalisbasedon48-weekdatafromt...urrentlymarketedintheU.S.byTibotecTherapeutics,adi...
(Date:11/25/2009)...-RegadoBiosciences,aprivatelyheldcompanyleadingthe...olagents,announcedthatDavidMazzo,PhD,CEOandPreside...thCareConferenceattheNewYorkPalaceHotelinNewYorkCi...nTuesday,December1andwillincludeanoverviewoftheCom...ram,theanticoagulantsystem,REG1.Thehealthcareindus...
(Date:11/25/2009)...rstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalprodu...ystems,announcedtodaythatClintSeverson,chairmanand...perJaffrayHealthCareConferenceonWednesday,December...YorkPalaceHotelinNewYorkCity. ,, AboutAbaxis ...ebloodanalysissystemsforuseinanyveterinaryorhumanp...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2
...t. 18 Forest,Laboratories (NYSE: FRX ) announced...duced a significant bronchodilatory response in 17...e IIa trial presented today at the,European Respir...1) (Logo: http://www.newscom.com/cgi-bin/prnh/20...that mean FEV1 and FVC values - important,measures...
... http://www.wilsoncenter.org/globalhealth , WASHI...e W. Bush called for a reauthorization of the Pres...hich is set to expire at the end,of fiscal year 20... the,initial 2003 commitment of $15 billion to $30...20, 2007, the Woodrow Wilson Center,s Global Healt...
Other Medicine Technology:Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 2Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 3Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 4Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 5Director's Forum: PEPFAR and the Global AIDS Response 2
...the user to quickly and accurately count bacteria ...unting or manual counting. An optional 1.5X auxili...gnification to 3.0X. The adjustable focusing rod a...ed. The lens also rotates a full 360 for ready acc...
...the user to quickly and accurately count bacteria ...unting or manual counting. An optional 1.5X auxili...gnification to 3.0X. The adjustable focusing rod a...ed. The lens also rotates a full 360 for ready acc...
Accucount 2000 (115V/60Hz)
Accucount 1000 (115V/60Hz)
Medicine Products: